{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:36:08Z","timestamp":1762756568105,"version":"build-2065373602"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Primary Sj\u00f6gren\u2019s syndrome (pSS) is a heterogeneous autoimmune disorder that may be associated with systemic manifestations such as pulmonary or articular involvement.Compared to other autoimmune diseases, vascular injury and accelerated atherosclerosis in pSS are less studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 51-year-old woman presented with a 2-month history of dizziness, chest tightness, and exertional dyspnea. Vascular imaging revealed multifocal stenoses in the left anterior descending coronary artery (70%), bilateral middle cerebral arteries, right anterior cerebral artery, and left posterior cerebral artery. Her only traditional cardiovascular risk factor was hypertension, and she reported only mild xerostomia. Serology showed anti-SSA positivity. Schirmer\u2019s test was abnormal, and a labial gland biopsy confirmed focal lymphocytic sialadenitis (\u22651 foci\/4 mm\u00b2), leading to a pSS diagnosis per 2016 ACR-EULAR criteria. She responded favorably to a combination of immunomodulators (hydroxychloroquine and total glucosides of paeony), antiplatelet therapy, and statins, with symptom resolution at follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case represents an exceptionally rare documented instance of pSS simultaneously affecting both cerebral and coronary arterial systems. It underscores that severe multifocal arterial stenosis can present as the initial manifestation of this disease, even in the absence of prominent dryness symptoms. This highlights the necessity for vascular assessment in pSS patients and the urgency of conducting autoimmune evaluations in cases of unexplained multivessel arteriopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1696571","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:31:29Z","timestamp":1762756289000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: A Chinese woman with primary Sj\u00f6gren\u2019s syndrome presented with simultaneous involvement of the cerebral and coronary arteries as initial symptoms"],"prefix":"10.3389","volume":"16","author":[{"given":"JiaQi","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZeXian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ChenChen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary sjogren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20117","article-title":"Functional impairment of the arterial wall in primary Sjogren\u2019s syndrome: combined action of immunologic and inflammatory factors","volume":"62","author":"Gerli","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0599-5","article-title":"Endothelial dysfunction in patients with primary Sjogren\u2019s syndrome","volume":"25","author":"Pirildar","year":"2005","journal-title":"Rheumatol Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4265-1","article-title":"Association between primary Sjogren\u2019s syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis","volume":"38","author":"Yong","year":"2019","journal-title":"Clin Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310367504","article-title":"Cardiovascular risk factors in primary Sjogren\u2019s syndrome: a case-control study in 624 patients","volume":"19","author":"Perez-De-Lis","year":"2010","journal-title":"Lupus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22227","article-title":"Cardiovascular risk factors in women with primary Sjogren\u2019s syndrome: United Kingdom primary Sjogren\u2019s syndrome registry results","volume":"66","author":"Juarez","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3072-1","article-title":"Metabolic syndrome in Sjogren\u2019s syndrome patients: a relevant concern for clinical monitoring","volume":"35","author":"Augusto","year":"2016","journal-title":"Clin Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00817","article-title":"Subclinical atherosclerosis in primary sj\u00f6gren\u2019s syndrome: does inflammation matter","volume":"10","author":"Bartoloni","year":"2019","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejim.2023.11.007","article-title":"Risk of subclinical atherosclerosis in primary Sjogren\u2019s syndrome: A systematic review and meta-analysis","volume":"122","author":"Karakasis","year":"2024","journal-title":"Eur J Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/iep.12061","article-title":"Neovascularization is prominent in the chronic inflammatory lesions of Sj\u00f6gren\u2019s syndrome","volume":"95","author":"Sisto","year":"2014","journal-title":"Int J Exp Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-08-1169","article-title":"Endothelial dysfunction: the first step toward coronary arteriosclerosis","volume":"73","author":"Vanhoutte","year":"2009","journal-title":"Circ journal : Off J Japanese Circ Soc"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2012.039","article-title":"Endothelial dysfunction in primary Sj\u00f6gren syndrome","volume":"61","author":"Akyel","year":"2012","journal-title":"West Indian Med J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2741\/s405","article-title":"Causes and consequences of low grade endotoxemia and inflammatory diseases","volume":"5","author":"Glaros","year":"2013","journal-title":"Front bioscience (Scholar edition)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/antiox11101958","article-title":"Roles of oxidative stress and inflammation in vascular endothelial dysfunction-related disease","volume":"11","author":"Higashi","year":"2022","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199603000-00037","article-title":"Multiple cerebral arterial occlusions in a young patient with Sjogren\u2019s syndrome: case report","volume":"38","author":"Nagahiro","year":"1996","journal-title":"Neurosurgery"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.02.022","article-title":"Efficacy of extracranial-intracranial bypass for progressive middle cerebral artery occlusion associated with active Sjogren\u2019s syndrome: case report","volume":"23","author":"Sakata","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1038\/s41598-018-19580-y","article-title":"Increased risk of coronary heart disease among patients with primary Sjogren\u2019s syndrome: a nationwide population-based cohort study","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sjogren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e001064","DOI":"10.1136\/rmdopen-2019-001064","article-title":"Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjogren\u2019s syndrome","volume":"5","author":"Brito-Zeron","year":"2019","journal-title":"RMD Open"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30057-6","article-title":"Leflunomide-hydroxychloroquine combination therapy in patients with primary Sjogren\u2019s syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial","volume":"2","author":"van der Heijden","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30135-3","article-title":"Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjogren\u2019s syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study","volume":"2","author":"Fisher","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02251-0","article-title":"Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjogren\u2019s syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial","volume":"399","author":"Bowman","year":"2022","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.3390\/jcm9113469","article-title":"Cardiovascular protection of hydroxychloroquine in patients with sjogren\u2019s syndrome","volume":"9","author":"Yang","year":"2020","journal-title":"J Clin Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20230803-00141","article-title":"Clinical practice guidelines for the treatment of primary Sjogren\u2019s syndrome by off-label drug use in China(2023 edition)","volume":"103","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2025.03.043","article-title":"Paeoniflorin alleviated experimental Sjogren\u2019s syndrome by inhibiting NLRP3 inflammasome activation of submandibular gland cells via activating Nrf2\/HO-1 pathway","volume":"233","author":"Jiang","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311X00310520","article-title":"Primary healthcare in rural areas: access, organization, and health workforce in an integrative literature review","volume":"37","author":"Franco","year":"2021","journal-title":"Cadernos saude publica"},{"key":"B28","doi-asserted-by":"publisher","first-page":"23359","DOI":"10.1038\/s41598-024-74816-4","article-title":"Urban and rural disparities in general hospital accessibility within a Chinese metropolis","volume":"14","author":"Du","year":"2024","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1394527","article-title":"Survey and analysis on the resource situation of primary health care institutions in rural China","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.3390\/ijerph17113848","article-title":"The urban-rural disparity in the status and risk factors of health literacy: A cross-sectional survey in central China","volume":"17","author":"Wang","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020547","article-title":"Prevalence and risk factors of low health literacy in residents of Anhui province: A cross-sectional survey","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/pr.2015.192","article-title":"Addressing health disparities in rural communities using telehealth","volume":"79","author":"Marcin","year":"2016","journal-title":"Pediatr Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1696571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T06:31:45Z","timestamp":1762756305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1696571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2025.1696571"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1696571","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"article-number":"1696571"}}